$INM SEC Filings

Filed On	Filing
20 Oct 2026	Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other Bought 1 shares ($1.32) · Bought 1,086 shares ($1.43K)
15 Oct 2026	Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other Bought 564 shares ($750) · Bought 8,021 shares ($10.7K) · Bought 984 shares ($1.3K)
08 Oct 2026	Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other Bought 5,601 shares ($7.44K) · Bought 3,046 shares ($4.05K) · Bought 2,256 shares ($3K)
07 Oct 2026	SCHEDULE 13G/A
05 Oct 2026	Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other Bought 16,431 shares ($21.8K) · Bought 8,307 shares ($11K) · Bought 18,182 shares ($24.2K)
01 Oct 2026	EFFECT
01 Oct 2026	424B3
29 Sep 2026	S-4/A
18 Sep 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events Vancouver, BC – September 18, 2026 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unme...
16 Sep 2026	Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other Bought 28,505 shares ($36.9K) · Bought 54,256 shares ($70.4K) · Bought 8,340 shares ($10.8K)
09 Sep 2026	FORM 425
09 Sep 2026	S-4/A
09 Sep 2026	ANNUAL REPORT
14 Aug 2026	SCHEDULE 13G
22 Jul 2026	FORM 425
22 Jul 2026	CURRENT REPORT
22 Jul 2026	8-K: Regulation FD Disclosure; Other Events
20 Jul 2026	FORM 425
17 Jul 2026	Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other Bought 1,000 shares ($1.56K)
16 Jul 2026	Form 4: Vivo Opportunity, Llc, 10% owner and 3 others Bought 5,375 shares ($8.33K) · Bought 15,150 shares ($23.5K) · Bought 21 shares ($32.6)

Comments